Inhibition of SARS-CoV-2 infection (previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
about
Inhibition of SARS-CoV-2 infection (previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
description
artículu científicu espublizáu'l 12 de marzu de 2020
@ast
scientific article (preprint)
@en
name
Inhibition of SARS-CoV-2 infec ...... ity to mediate membrane fusion
@ast
Inhibition of SARS-CoV-2 infec ...... ity to mediate membrane fusion
@en
type
label
Inhibition of SARS-CoV-2 infec ...... ity to mediate membrane fusion
@ast
Inhibition of SARS-CoV-2 infec ...... ity to mediate membrane fusion
@en
prefLabel
Inhibition of SARS-CoV-2 infec ...... ity to mediate membrane fusion
@ast
Inhibition of SARS-CoV-2 infec ...... ity to mediate membrane fusion
@en
P2093
P921
P1433
P1476
Inhibition of SARS-CoV-2 infec ...... ity to mediate membrane fusion
@en
P2093
Lanying Du
Linlin Bao
Meiqin Liu
Qiaoshuai Lan
Shibo Jiang
P2536
P356
10.1101/2020.03.09.983247
P407
P50
P577
2020-03-12T00:00:00Z
P6179
1125610164